Ed Reznik
Impact in
- Cancer Research top 0.05%
- Cancer Genomics and Diagnostics
- Cancer-related molecular mechanisms research
- Cancer, Hypoxia, and Metabolism
- Breast Cancer Treatment Studies
- Oncology top 0.1%
- Cancer Immunotherapy and Biomarkers
Papers in
-
- Cancer Genomics and Diagnostics 36
- Cancer, Hypoxia, and Metabolism 18
-
- Renal cell carcinoma treatment 47
- Co-authors
- Chris Sander (8 shared papers)A. Ari Hakimi (38 shared papers)Satish K. Tickoo (7 shared papers)William E. Lee (2 shared papers)Daniel Segrè (8 shared papers)Εlad Noor (3 shared papers)Bülent Arman Aksoy (3 shared papers)Yasin Şenbabaoğlu (2 shared papers)
- Journals
- Cell Reports (19 papers)Cell (14 papers)Cancer Cell (9 papers)The Journal of Urology (6 papers)European Urology Focus (5 papers)
- Partner nations
- United StatesUnited KingdomGermany
In The Last Decade
Ed Reznik
127 papers receiving 32.3k citations
Ed Reznik's Hit Papers
Peers
Comparison fields: 5 of 159
- Cancer Research 8.5k
- Oncology 7.9k
- Pulmonary and Respiratory Medicine 6k
- Molecular Biology 9.4k
- Genetics 1k
Countries citing papers authored by Ed Reznik
This map shows the geographic impact of Ed Reznik's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ed Reznik with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ed Reznik more than expected).
Fields of papers citing papers by Ed Reznik
This network shows the impact of papers produced by Ed Reznik. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ed Reznik. The network helps show where Ed Reznik may publish in the future.
Co-authors
The 25 scholars most cited alongside Ed Reznik, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 137 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | The Immune Landscape of Cancer Hit paper breakdown → | 2018 | 4385 |
| 2 | An Integrated TCGA Pan-Cancer Clinical Data Resource to Drive High-Quality Survival Outcome Analytics Hit paper breakdown → | 2018 | 2633 |
| 3 | Oncogenic Signaling Pathways in The Cancer Genome Atlas Hit paper breakdown → | 2018 | 2371 |
| 4 | Cell-of-Origin Patterns Dominate the Molecular Classification of 10,000 Tumors from 33 Types of Cancer Hit paper breakdown → | 2018 | 1758 |
| 5 | Comprehensive Characterization of Cancer Driver Genes and Mutations Hit paper breakdown → | 2018 | 1748 |
| 6 | Machine Learning Identifies Stemness Features Associated with Oncogenic Dedifferentiation Hit paper breakdown → | 2018 | 1634 |
| 7 | Genomic and Molecular Landscape of DNA Damage Repair Deficiency across The Cancer Genome Atlas Hit paper breakdown → | 2018 | 824 |
| 8 | Spatial Organization and Molecular Correlation of Tumor-Infiltrating Lymphocytes Using Deep Learning on Pathology Images Hit paper breakdown → | 2018 | 771 |
| 9 | Genomic and Functional Approaches to Understanding Cancer Aneuploidy Hit paper breakdown → | 2018 | 768 |
| 10 | Comprehensive Analysis of Alternative Splicing Across Tumors from 8,705 Patients Hit paper breakdown → | 2018 | 696 |
| 11 | The long tail of oncogenic drivers in prostate cancer Hit paper breakdown → | 2018 | 663 |
| 12 | Tracking Cancer Evolution Reveals Constrained Routes to Metastases: TRACERx Renal Hit paper breakdown → | 2018 | 651 |
| 13 | The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma Hit paper breakdown → | 2018 | 645 |
| 14 | An Integrated Metabolic Atlas of Clear Cell Renal Cell Carcinoma Hit paper breakdown → | 2016 | 617 |
| 15 | Pathogenic Germline Variants in 10,389 Adult Cancers Hit paper breakdown → | 2018 | 617 |
| 16 | Scalable Open Science Approach for Mutation Calling of Tumor Exomes Using Multiple Genomic Pipelines Hit paper breakdown → | 2018 | 598 |
| 17 | The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma Hit paper breakdown → | 2018 | 580 |
| 18 | Integrative Genomic Analysis of Cholangiocarcinoma Identifies Distinct IDH-Mutant Molecular Profiles Hit paper breakdown → | 2017 | 516 |
| 19 | A Comprehensive Pan-Cancer Molecular Study of Gynecologic and Breast Cancers Hit paper breakdown → | 2018 | 470 |
| 20 | Driver Fusions and Their Implications in the Development and Treatment of Human Cancers Hit paper breakdown → | 2018 | 457 |
About Ed Reznik
Ed Reznik is a scholar working on Cancer Research, Pulmonary and Respiratory Medicine, Molecular Biology, Oncology and Endocrinology, Diabetes and Metabolism, having authored 137 papers that have together received 32.7k indexed citations. Recurring topics across this work include Renal cell carcinoma treatment (47 papers), Cancer Genomics and Diagnostics (36 papers), Cancer, Hypoxia, and Metabolism (18 papers), Cancer Immunotherapy and Biomarkers (9 papers), Mitochondrial Function and Pathology (9 papers), Microbial Metabolic Engineering and Bioproduction (9 papers), Metabolomics and Mass Spectrometry Studies (5 papers) and Gene Regulatory Network Analysis (4 papers). The work is most often cited by research in Cancer Research (8.5k citations), Oncology (7.9k citations), Pulmonary and Respiratory Medicine (6k citations), Molecular Biology (9.4k citations) and Genetics (1k citations). Ed Reznik has collaborated with scholars based in United States, United Kingdom and Germany. Frequent co-authors include Chris Sander, A. Ari Hakimi, Satish K. Tickoo, William E. Lee, Daniel Segrè, Εlad Noor, Bülent Arman Aksoy, Yasin Şenbabaoğlu, Eric Minwei Liu and Martin L. Miller. Their work appears in journals such as Cell Reports, Cell, Cancer Cell, The Journal of Urology and European Urology Focus.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.